A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis
Clinical trial NCT00721123 · COMPLETED
Trial details
- NCT number
- NCT00721123
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2012-05-01
- Enrollment
- 538
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.